Allspring Global Investments
RPRX icon

Allspring Global Investments’s Royalty Pharma RPRX Stock Holding History

Allspring Global Investments’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Buy
27,426
+198
+0.7% +$10.3K ﹤0.01% 1127
2026
Q1 		$1.33M Buy
27,228
+454
+2% +$19.9K ﹤0.01% 1123
2025
Q4 		$1.05M Buy
26,774
+2,088
+8% +$79.6K ﹤0.01% 1148
2025
Q3 		$897K Buy
24,686
+138
+0.6% +$5K ﹤0.01% 1190
2025
Q2 		$881K Sell
24,548
-537,176
-96% -$17.8M ﹤0.01% 1195
2025
Q1 		$17.5M Buy
561,724
+21,729
+4% +$689K 0.03% 559
2024
Q4 		$13.9M Buy
539,995
+406,123
+303% +$10.8M 0.02% 648
2024
Q3 		$3.79M Sell
133,872
-176,980
-57% -$4.9M 0.01% 1024
2024
Q2 		$8.2M Buy
310,852
+308,102
+11,204% +$8.54M 0.01% 822
2024
Q1 		$83.5K Buy
2,750
+2,688
+4,335% +$79.2K ﹤0.01% 1875
2023
Q4 		$1.74K Buy
62
+2
+3% +$55 ﹤0.01% 2112
2023
Q3 		$1.63K Buy
60
+18
+43% +$535 ﹤0.01% 2720
2023
Q2 		$1.29K Sell
42
-4,275
-99% -$145K ﹤0.01% 2653
2023
Q1 		$156K Sell
4,317
-663,013
-99% -$24.6M ﹤0.01% 1891
2022
Q4 		$26.4M Sell
667,330
-588,474
-47% -$24.6M 0.05% 498
2022
Q3 		$50.5M Buy
1,255,804
+361,969
+40% +$15.5M 0.09% 295
2022
Q2 		$37.6M Buy
893,835
+877,718
+5,446% +$36M 0.06% 394
2022
Q1 		$627K Sell
16,117
-10,039
-38% -$394K ﹤0.01% 2126
2021
Q4 		$1.04M Buy
+26,156
New +$1.02M ﹤0.01% 1910

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments's RPRX Position: Q2 2026 in Review

Allspring Global Investments increased its Royalty Pharma (RPRX) stake by 0.73% in Q2 2026, buying an estimated $10.3K and bringing the position to 27,426 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1127.

Allspring Global Investments first reported a position in RPRX in Q4 2021 and has held it in 19 quarters since. The position peaked at $50.5M in Q3 2022. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Allspring Global Investments held 27,426 shares of Royalty Pharma worth $1.53M as of Q2 2026.
  • Allspring Global Investments bought 198 Royalty Pharma shares in Q2 2026, an estimated $10.3K.
  • Royalty Pharma made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1127 holding.
  • Allspring Global Investments first reported a position in Royalty Pharma in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's Royalty Pharma position peaked at $50.5M in Q3 2022.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.